Selective Vein Graft Cold Cardioplegia and Warm Reperfusion to Enhance Early Recovery in Patients with Left Ventricle

Pasquale Totaro1, Martina Musto1, Eduardo Tulumello2

  • 1Cardiac Surgery, IRCCS Foundation Hospital San Matteo, 27100 Pavia, Italy.

Insights

Total antegrade cardioplegia infusion and warm reperfusion (TAWR) significantly improves early cardiac recovery in patients with depressed left ventricular function undergoing multi-vessel coronary artery bypass grafting (CABG). This strategy enhances spontaneous rhythm recovery and reduces the need for inotropic support post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Myocardial Protection

Background:

  • Antegrade root cardioplegia is standard for myocardial protection during coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB).
  • Patients with depressed left ventricular function (EF < 40%) undergoing multi-vessel CABG often require enhanced support for left ventricular recovery post-CPB.
  • Severe multi-vessel coronary stenosis exacerbates the need for improved myocardial protection strategies in these vulnerable patients.

Purpose of the Study:

  • To evaluate the efficacy of a novel myocardial protection strategy, total antegrade cardioplegia infusion and warm reperfusion (TAWR), in improving early postoperative recovery.
  • To compare the TAWR strategy against standard antegrade root cardioplegia with limited warm reperfusion (SAWR) in patients with depressed left ventricular function undergoing multi-vessel CABG.
  • To assess key outcomes including spontaneous rhythm recovery, inotropic support requirements, and troponin release.

Main Methods:

  • A prospective study involving 97 patients undergoing CABG with TAWR, with 32 patients (Group A) meeting criteria for depressed left ventricular function (EF < 40%) and multi-vessel disease requiring ≥2 vein grafts.
  • Group A was compared with 32 matched patients (Group B) who underwent CABG using the standard antegrade root cardioplegia and limited warm reperfusion (SAWR) strategy.
  • Outcomes analyzed included in-hospital mortality, spontaneous rhythm recovery, early and prolonged inotropic support, and postoperative troponin levels.

Main Results:

  • No significant difference in in-hospital mortality between the TAWR (Group A) and SAWR (Group B) groups (3.1%).
  • TAWR significantly improved spontaneous recovery of idiopathic rhythm (90% in Group A vs. 53% in Group B, p=0.001).
  • TAWR reduced the need for early inotropic support (28% in Group A vs. 53% in Group B, p=0.041) and prolonged inotropic support (>48h) (25% in Group A vs. 53% in Group B, p=0.039).

Conclusions:

  • The total antegrade cardioplegia infusion and warm reperfusion (TAWR) strategy significantly enhances early postoperative cardiac recovery in patients with depressed left ventricular function undergoing multi-vessel CABG.
  • TAWR demonstrates superior outcomes in spontaneous rhythm recovery and reduced reliance on inotropic support compared to the standard antegrade root cardioplegia and limited warm reperfusion (SAWR) strategy.
  • The TAWR strategy is recommended as the preferred approach for myocardial protection in this high-risk patient subset.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762